Teva Unit Enters $10M Settlement With Depomed
Teva Pharmaceutical Industry Ltd. and a subsidiary reached a $10 million settlement with specialty pharmaceutical company Depomed Inc. on Monday, resolving a suit over Depomed's patented controlled-release drug delivery technology....To view the full article, register now.
Already a subscriber? Click here to view full article